CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer
Wonkyo Shin, Hye-joo Lee, Seong J. Yang, E sun Paik, Hyun-jin Choi, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim
Obstet Gynecol Sci. 2018;61(3):352-358.   Published online May 9, 2018
DOI: https://doi.org/10.5468/ogs.2018.61.3.352

Excel Download

Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer
Obstetrics & Gynecology Science. 2018;61(3):352   Crossref logo
Link1 Link2 Link3

Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer
Journal of Korean Medical Science. 2009;24(5):945   Crossref logo
Link1 Link2 Link3

Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
Cancer Research and Treatment. 2013;45(1):40-47   Crossref logo
Link1 Link2

Combination chemotherapy with cisplatin, ifosfamide and etoposide for small cell lung cancer
Lung Cancer. 1991;7:121   Crossref logo
Link1 Link2

The results of combination chemotherapy with etoposide, ifosfamide and cisplatin in patients with lung cancer (A preliminary report)
Lung Cancer. 1995;12(1-2):142   Crossref logo
Link1 Link2

Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer
Gynecologic Oncology. 2012;124(1):171   Crossref logo
Link1 Link2

Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer
Yearbook of Oncology. 2011;2011:75-76   Crossref logo
Link1 Link2

Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer
Yearbook of Medicine. 2011;2011:155-156   Crossref logo
Link1 Link2

Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer
International Journal of Clinical Oncology. 2010;15(5):468-471   Crossref logo
Link1 Link2 Link3

Chemotherapy for Primary and Recurrent Epithelial Ovarian Cancer
Ovarian Cancer - From Pathogenesis to Treatment. 2018;   Crossref logo
Link1